RE: project management25 Oct 2018 13:36
Ray, you wrote:
"It clearly shows Biotech's commitment to moditope."
Sorry Ray, but it does no such thing. You need to read the RNS. It states:
Quote......
Scancell to collaborate with BioNTech to INVESTIGATE T cell receptor based therapeutics for the treatment of cancer.
Agreement expands POTENTIAL therapeutic utility of Moditope® to adoptive T cell therapy
Under the terms of the agreement, Scancell and BioNTech will enter into an initial RESEARCH collaboration
…. Unquote
There is no COMMITMENT from BioNTech. If there is no synergy or benefit they will walk away. Hopefully there will be some synergy and depending on the commercial deal BioNtech MAY commit themselves.
If you want to ramp the share you really need to be a bit more factual and show a bit more subtlety.